Laurie Stelzer - Net Worth and Insider Trading
Laurie Stelzer Net Worth
The estimated net worth of Laurie Stelzer is at least $5 Million dollars as of 2024-09-20. Laurie Stelzer is the CFO of Mirati Therapeutics Inc and owns about 80,015 shares of Mirati Therapeutics Inc (MRTX) stock worth over $5 Million. Laurie Stelzer is also the CFO of Halozyme Therapeutics Inc and owns about 10,000 shares of Halozyme Therapeutics Inc (HALO) stock worth over $595,100. Details can be seen in Laurie Stelzer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Laurie Stelzer has not made any transactions after 2023-06-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Laurie Stelzer
Laurie Stelzer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Laurie Stelzer owns 5 companies in total, including PMV Pharmaceuticals Inc (PMVP) , Surface Oncology Inc (SURF) , and Arena Pharmaceuticals Inc (ARNA) among others .
Click here to see the complete history of Laurie Stelzer’s form 4 insider trades.
Insider Ownership Summary of Laurie Stelzer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PMVP | PMV Pharmaceuticals Inc | 2020-09-24 | director |
| SURF | Surface Oncology Inc | 2018-04-18 | director |
| ARNA | Arena Pharmaceuticals Inc | 2020-03-16 | EVP & Chief Financial Officer |
 | | 2015-08-20 | SVP & CFO |
| | 2023-06-02 | CFO |
Laurie Stelzer Latest Holdings Summary
Laurie Stelzer currently owns a total of 2 stocks. Among these stocks, Laurie Stelzer owns 80,015 shares of Mirati Therapeutics Inc (MRTX) as of June 2, 2023, with a value of $5 Million and a weighting of 88.75%. Laurie Stelzer also owns 10,000 shares of Halozyme Therapeutics Inc (HALO) as of August 20, 2015, with a value of $595,100 and a weighting of 11.25%.
Latest Holdings of Laurie Stelzer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MRTX | Mirati Therapeutics Inc | 2023-06-02 | 80,015 | 58.70 | 4,696,881 |
| HALO | Halozyme Therapeutics Inc | 2015-08-20 | 10,000 | 59.51 | 595,100 |
Holding Weightings of Laurie Stelzer
Laurie Stelzer Form 4 Trading Tracker
According to the SEC Form 4 filings, Laurie Stelzer has made a total of 1 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Mirati Therapeutics Inc is the sale of 4,647 shares on June 2, 2023, which brought Laurie Stelzer around $172,218.
According to the SEC Form 4 filings, Laurie Stelzer has made a total of 0 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years. The most-recent trade in Halozyme Therapeutics Inc is the acquisition of 10,000 shares on August 20, 2015, which cost Laurie Stelzer around $172,400.
Insider Trading History of Laurie Stelzer
- 1
Laurie Stelzer Trading Performance
GuruFocus tracks the stock performance after each of Laurie Stelzer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Laurie Stelzer is 1.46%. GuruFocus also compares Laurie Stelzer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Laurie Stelzer within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Laurie Stelzer's insider trading performs compared to the benchmark.
Performance of Laurie Stelzer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.58 | | | | | |
| Relative Return to S&P 500(%) | 15.4 | | | | | |
Laurie Stelzer Ownership Network
Laurie Stelzer Owned Company Details
What does PMV Pharmaceuticals Inc do?
Who are the key executives at PMV Pharmaceuticals Inc?
Laurie Stelzer is the director of PMV Pharmaceuticals Inc. Other key executives at PMV Pharmaceuticals Inc include SVP & Regulatory Affairs and QA Deepika Jalota , 10 percent owner Orbimed Advisors Llc , and Chief Medical Officer Leila Alland .
PMV Pharmaceuticals Inc (PMVP) Insider Trades Summary
Over the past 18 months, Laurie Stelzer made no insider transaction in PMV Pharmaceuticals Inc (PMVP). Other recent insider transactions involving PMV Pharmaceuticals Inc (PMVP) include a net sale of 11,322 shares made by Deepika Jalota , a net sale of 87,786 shares made by Orbimed Advisors Llc , and a net sale of 6,291 shares made by Leila Alland .
In summary, during the past 3 months, insiders sold 10,109 shares of PMV Pharmaceuticals Inc (PMVP) in total and bought 0 shares, with a net sale of 10,109 shares. During the past 18 months, 108,290 shares of PMV Pharmaceuticals Inc (PMVP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 108,290 shares.
PMV Pharmaceuticals Inc (PMVP)'s detailed insider trading history can be found in Insider Trading Tracker table.
PMV Pharmaceuticals Inc Insider Transactions
Laurie Stelzer Mailing Address
Above is the net worth, insider trading, and ownership report for Laurie Stelzer. You might contact Laurie Stelzer via mailing address: 6154 Nancy Ridge Drive, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
